Javascript must be enabled to continue!
KLRG1, Cadherins and their Interaction (35.29)
View through CrossRef
Abstract
The killer cell lectin-like receptor G1 (KLRG1) is a unique inhibitory receptor expressed on a phenotypically mature subset of resting NK cells as well as effector memory CD8+ T cells. KLRG1 is a C-type lectin inhibitory receptor that contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic domain. KLRG1 ligands have been recently identified and are members of the broadly expressed cadherin family, N-, R-, and E-cadherin. In this study, we attempt to elucidate the consequences of cadherin engagement by KLRG1 as well as KLRG1 engagement by cadherin. We found that E-cadherin engagement by KLRG1 influences the dynamics of cell adhesion. Along this line, we showed that E-cadherin and KLRG1 interaction regulates the signaling properties of E-cadherin. These data are supported by the fact that recombinant extracellular domain of N-cadherin blocks KLRG1 tetramer binding to cadherin expressing cells. In addition, we show that recombinant extracellular domain of N-cadherin functions to regulate KLRG1 signaling. We also demonstrated ex vivo that KLRG1 engagement by E-cadherin induces a significant inhibition of TCR signaling. Notably, upon analysis of E-cadherin mutants, we discovered that E-cadherin’s cytoplasmic domain regulates its cell surface expression. Taken together, our data suggest that immune receptor interaction with cadherin may have an impact not only on immune cells such as NK cells but also on cells expressing cadherin such as epithelial cells. Supported by NIH grant AI 58181.
Oxford University Press (OUP)
Title: KLRG1, Cadherins and their Interaction (35.29)
Description:
Abstract
The killer cell lectin-like receptor G1 (KLRG1) is a unique inhibitory receptor expressed on a phenotypically mature subset of resting NK cells as well as effector memory CD8+ T cells.
KLRG1 is a C-type lectin inhibitory receptor that contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic domain.
KLRG1 ligands have been recently identified and are members of the broadly expressed cadherin family, N-, R-, and E-cadherin.
In this study, we attempt to elucidate the consequences of cadherin engagement by KLRG1 as well as KLRG1 engagement by cadherin.
We found that E-cadherin engagement by KLRG1 influences the dynamics of cell adhesion.
Along this line, we showed that E-cadherin and KLRG1 interaction regulates the signaling properties of E-cadherin.
These data are supported by the fact that recombinant extracellular domain of N-cadherin blocks KLRG1 tetramer binding to cadherin expressing cells.
In addition, we show that recombinant extracellular domain of N-cadherin functions to regulate KLRG1 signaling.
We also demonstrated ex vivo that KLRG1 engagement by E-cadherin induces a significant inhibition of TCR signaling.
Notably, upon analysis of E-cadherin mutants, we discovered that E-cadherin’s cytoplasmic domain regulates its cell surface expression.
Taken together, our data suggest that immune receptor interaction with cadherin may have an impact not only on immune cells such as NK cells but also on cells expressing cadherin such as epithelial cells.
Supported by NIH grant AI 58181.
Related Results
Role of the KLRG1 pathway in the immune response
Role of the KLRG1 pathway in the immune response
Abstract
Killer cell lectin-like receptor G1 (KLRG1) is a C-type lectin inhibitory receptor that contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in...
Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling
Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling
AbstractKLRG1 is an inhibitory receptor expressed on a subset of mature T and NK cells. Recently, E-, N-, and R-cadherin have been identified as ligands for KLRG1. Cadherins are a ...
KLRG1, Cadherins and their Interactions
KLRG1, Cadherins and their Interactions
The killer cell lectin‐like receptor G1 (KLRG1) is a unique inhibitory receptor expressed on a phenotypically mature subset of resting NK cells as well as effector memory CD8+ T ce...
Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus
Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus
IntroductionSystemic lupus erythematosus (SLE) patients are predisposed to chronic immune activation, leading to accelerated immunosenescence. The aging of the immune system causes...
Assessment the Diversity of Circulating Natural Killer Cells Between Active Tuberculosis and Latent Tuberculosis Infection
Assessment the Diversity of Circulating Natural Killer Cells Between Active Tuberculosis and Latent Tuberculosis Infection
Abstract
Background: Tuberculosis (TB) is a leading global public health problem, but the mechanisms underlying the immunopathology of TB progression are not well understoo...
Determining antitumor responses to variable cadherin expression
Determining antitumor responses to variable cadherin expression
Abstract
Cancer immunotherapy has dramatically transformed the treatment of many cancers. Despite this, several limitations exist. For example, in some patients’ can...
Mechanisms of E-cadherin force transmission
Mechanisms of E-cadherin force transmission
<p>Cells are subject to a wide variety of forces throughout their lifetimes. During epithelial morphogenesis, epithelial cells form sheets of cells that line the cavities and...
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment
Checkpoint blockade therapy (CBT) involving anti-PD1 antibodies represents the standard approach for cHL patients who do not respond to second-line therapy. Nonetheless, only 20% o...

